ClinVar Miner

Submissions for variant NM_001271.4(CHD2):c.608A>G (p.Lys203Arg)

gnomAD frequency: 0.00256  dbSNP: rs117844037
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000246416 SCV000520449 benign not specified 2018-02-15 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000474584 SCV000563085 benign Developmental and epileptic encephalopathy 94 2024-02-01 criteria provided, single submitter clinical testing
Ambry Genetics RCV002313980 SCV000848930 likely benign Inborn genetic diseases 2018-07-02 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Genetic Services Laboratory, University of Chicago RCV000246416 SCV002071219 benign not specified 2017-12-18 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001700021 SCV002545316 benign not provided 2024-05-01 criteria provided, single submitter clinical testing CHD2: BP4, BS1, BS2
Fulgent Genetics, Fulgent Genetics RCV000474584 SCV002808871 likely benign Developmental and epileptic encephalopathy 94 2022-04-01 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV001700021 SCV005214039 likely benign not provided criteria provided, single submitter not provided
PreventionGenetics, part of Exact Sciences RCV004529426 SCV000307180 benign CHD2-related disorder 2021-03-03 no assertion criteria provided clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV001700021 SCV001927053 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001700021 SCV001966956 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.